Navigation Links
NeurogesX Reports First Quarter 2011 Results
Date:4/29/2011

concept, resulting in the commercial launch of Qutenza® (capsaicin) 8% patch in 2010. The Company continues to apply its knowledge and expertise in the development of other novel treatments for pain.

The Company's lead product, Qutenza, is a localized dermal delivery system containing prescription strength capsaicin that is currently approved in the United States and the European Union. Qutenza is now available in the United States for the management of neuropathic pain associated with postherpetic neuralgia (PHN). In Europe, Qutenza is being marketed by Astellas Pharma Europe Ltd. (Astellas), the European subsidiary of Tokyo-based Astellas Pharma Inc., for the treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in combination with other medicinal products for pain.

The Company is currently preparing to submit a supplemental new drug application (sNDA) to expand the U.S. label for Qutenza for the management of pain due to HIV-associated neuropathy (HIV-AN) also known as HIV-distal sensory polyneuropathy (HIV-DSP).

The Company's most advanced product candidate, NGX-1998, is a topically applied liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions such as PHN. NGX-1998 has completed three Phase 1 studies and patient dosing is underway in a Phase 2 clinical trial in PHN patients.

The Company's early-stage pipeline includes pre-clinical compounds which are prodrugs of acetaminophen and various opioids. The Company has evaluated certain of these compounds in vitro and in vivo.

Safe Harbor Statement This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the Act). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in th
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. NeurogesX Receives Notice of Allowance for Patent Covering NGX-1998 Capsaicin Topical Liquid
2. NeurogesX Reports Fourth Quarter and Year-End 2010 Results
3. NeurogesX to Provide Qutenza® Launch Update
4. NeurogesX to Present at Two February Investor Conferences
5. NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
6. NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation
7. NeurogesX to Hold Conference Call to Discuss Third Quarter 2010 Results
8. NeurogesX to Present at Oppenheimer & Co Healthcare Conference
9. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
10. NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
11. NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015 Kalorama Information says that ... to be robust; the market is driven by ... global markets, new product innovations and increasing life ... market inhibitors, such as government restraints, limited hospital ... The healthcare market research publisher,s report, Insulin ...
(Date:4/20/2015)... , April 20, 2015  Published results ... trends in the ability of Neuraltus Pharmaceuticals ... of amyotrophic lateral sclerosis (ALS, also known as ... treatment period. While NP001,s slowing of decline in ... was not statistically significant, clinically meaningful slowing of ...
(Date:4/20/2015)... ADDISON, Texas , April 20, 2015 /PRNewswire/ ... have entered a settlement agreement with Inter-Mountain Capital ... with a warrant exercise. Under ... 361,516 shares of Common Stock, issued an unsecured ... Warrant to purchase 194,118 shares of Common Stock ...
Breaking Medicine Technology:Kalorama: Insulin Pump Market Growing Robustly 2Kalorama: Insulin Pump Market Growing Robustly 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5ULURU Inc. Announces the Settlement of Outstanding Litigation 2
... ANGELES, Jan. 5, 2012 /PRNewswire-iReach/ -- Gentech Pharmaceutical, ... Golden Globe Awards introducing new products and giving away freebies ... include its flagship weight loss product, PhenTabz as part of ... celebrities at the upcoming Golden Globe awards in the GBK ...
... /PRNewswire-iReach/ -- FutureNet,s Ambulatory Electronic Health Record ... stamp of approval by earning ONC-ATCB certification. The ... of enabling ambulatory/outpatient providers to qualify for funding ... Tested and certified under the Drummond Group,s Electronic ...
Cached Medicine Technology:Golden Globe Awards Adds Gentech Pharmaceutical as New Participating Sponsor 2FutureNet Granted Certification for Cloud-based Ambulatory EHR 2FutureNet Granted Certification for Cloud-based Ambulatory EHR 3
(Date:4/21/2015)... 2015 As nationally recognized leaders ... various components of breast reconstruction research spanning both ... "Breast reconstruction research continues to significantly contribute to ... advances, many unanswered questions remain requiring continuous multifaceted ... results," says Dr. Oscar Ochoa emphasizing the importance ...
(Date:4/21/2015)... April 21, 2015 The Northeast Football ... beautiful Governor’s Academy prep school in Byfield, MA. Applications ... 2015, for boys entering grades 6-12. , The outstanding ... the players’ fall coaching. , Offensive and ... only are these the most unsung positions on the ...
(Date:4/21/2015)... Freeslate, Inc ., the leading ... announced that the Centre for Catalysis Research and ... acquired a Freeslate Core Module 3 (CM3) Reaction ... to accelerate current research programs. The systems will ... will be available to academic users and industrial collaborators/ ...
(Date:4/21/2015)... 21, 2015 This program provides ... therapist assistants, occupational therapist assistants, teachers, and other ... to help children across the autism spectrum succeed ... Education Resources Inc. , Used throughout ... highly acclaimed yoga curriculum addresses learning and behavior ...
(Date:4/20/2015)... 2015 Construction has reached completion ... Draft, an independent, nonprofit community hospital with existing ... The project was an ongoing collaboration between Timmons ... is expected to provide additional employment opportunities for ... Highway, the new facility features physician offices, a ...
Breaking Medicine News(10 mins):Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 2Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 3Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 4Health News:Research Performed at PRMA Expands Breast Reconstruction Knowledge 5Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3Health News:ABC News Interviews Anne Buckley-Reen, Education Resources Inc. Faculty Member, on Yoga Therapy in the Classroom 2Health News:Augusta Health Construction Wraps Up at Stuarts Draft 2
... knee arthritis can be helped by Exercise and patient’s ... in the April// issue of the Journal of Rheumatology. ... the treatment of the knee osteo-arthritis include physical ... analyzed sixteen studies and they have concluded that knowledge ...
... Russia has found that the deadly strain H5N1 strain of ... dead chickens found in Siberia all infected with the H5N1 ... dead chickens were from Omsk region. , The ... Novosibirsk virology and biotechnology centre Vektor, for inspection. Ilya Drozdov, ...
... the NHS has decided to go ahead with implementing some ... being the merger of the three ambulance services in Yorkshire ... the services is that it will save millions of pounds, ... Although this means that most managers and backroom staff will ...
... A Transient Ischemic Attack (TIA, or "mini-stroke") affects 300, 000 ... the symptoms would have subsided by the time they reach ... from a major stroke in 90 days with 64 percent ... cardiac event. ,In a paper presented at the ...
... a pact with the foreign ministry here to fund higher ... China in 2006-07. ,The students will receive a grant ... of the course in addition to the French foreign ministry's ... statement. ,"They will be invited to follow an ...
... themselves screened for HIV, city-run medical clinics have relaxed two ... new rule, counseling sessions and written informed consent is not ... a verbal consent from the patient. ,This rule ... with respect to consent and counseling. Two hospitals and city ...
Cached Medicine News:Health News:Prompt Diagnosis Could Be Life-Saving In Mini-Strokes 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: